184.26 Ohio biomedical development program.

(A) There is hereby created the Ohio biomedical development program to be administered by the third frontier commission. The commission shall provide loans, loan guarantees, or grants to for-profit or not-for-profit entities to promote, provide for and enable innovation, development and commercialization of biomedical and biotechnological products, processes and applications, including medical devices, diagnostics, informatics, therapies, and drugs, through efforts by and collaboration among and including business and industry in Ohio, state and local governmental entities and agencies, educational institutions, or research organizations and institutions. Any assistance made pursuant to this section shall be evidenced by an agreement, which shall contain such terms as the commission determines necessary or appropriate, including performance measures and reporting requirements. The commission may take actions necessary or appropriate to collect or otherwise deal with any assistance made under this section, including requiring a recipient of assistance to repay the amount of the assistance plus interest at a rate of three per cent above the federal short term interest rate or any other rate determined by the commission.

(B)

(1) As used in this section:

(a) "Human blastocyst" means an early stage human embryo that is five to seven days after conception. A blastocyst has an outer layer of cells known as a trophoblast, and an interior group of cells that is the inner cell mass.

(b) "Human cloning" means the creation of a human zygote, human blastocyst, or human embryo by any means other than the fertilization of a human egg by a human sperm.

(c) "Human embryo" means an organism of the species homo sapiens during the earliest stages of development from one cell up to eight weeks.

(d) "Human zygote" means a one-cell human embryo.

(2) Money received by an entity pursuant to the Ohio biomedical development program shall not be used, directly or indirectly, to pay costs of, or otherwise support any activities involving, human cloning.

Amended by 129th General AssemblyFile No.39, SB 171, §3, eff. 6/30/2011.

Repealed by 127th General AssemblyFile No.102, HB 554, §20, eff. 6/30/2011.

Prior History: (Effective Date: 2008 HB554 06-12-2008 )